Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Managing blood flow after spinal cord injuries

Official title: Hemodynamic Management Following Acute Traumatic Spinal Cord Injury: A Randomized, Controlled Trial

Run by The University of Texas Health Science Center, Houston · NCT06451133 · Data updated 2026-11-12

This study is testing different ways to manage blood flow in people with recent spinal cord injuries to see which method helps them recover better and avoid other health problems.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment228 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedJuly 3, 2024
Main results expectedSeptember 15, 2025
Study endsJuly 31, 2026
Registry record updatedDecember 11, 2024
Trial IDNCT06451133 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals who have sustained a traumatic spinal cord injury.

Probably not a fit

Patients with penetrating spinal cord injuries or severe preexisting conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates different hemodynamic management strategies to improve functional neurologic outcomes and reduce non-neurologic adverse events in patients with acute spinal cord injuries. Participants will be assigned to one of three management strategies: targeting a mean arterial blood pressure (MAP) of 85-90 mmHg, a spinal cord perfusion pressure (SCPP) of ≥65 mmHg, or maintaining normal hemodynamics with a MAP of ≥65 mmHg. The assessment will occur within the first five days following the injury to determine the effectiveness of these approaches.

Why it matters

Potential benefit: If successful, this study could lead to improved recovery outcomes for patients with acute spinal cord injuries.

How similar studies have gone: Other studies have explored hemodynamic management in spinal cord injuries, but this specific approach is novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Traumatic spinal cord injury

Exclusion Criteria:

* Patients with an injury from a trauma that penetrates the spinal cord (i.e., gunshot or knife wound resulting in cord transection)
* Preexisting neurologic or spinal cord injury
* Severe traumatic brain injury as measured by a best resuscitated Glasgow Coma Scale (GCS) score of \<8 at 24 hours following injury
* Presence of traumatic injuries that preclude spine surgery within 24 hours of presentation
* Concomitant injury/illness requiring targeted blood pressure management (e.g., injury to the aorta, aortic dissection, hemorrhagic stroke)
* Preexisting history of neuromotor disorders (i.e., cerebral palsy, Parkinson disease, etc.)
* Not expected to survive \>24h
* Cord transection identified by radiologist and agreed upon by the spine surgery team
* Injury below spinal cord level L1
* Prisoners
* Pregnant women

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: David Meyer, MD, MS, FACS — The University of Texas Health Science Center, Houston
  • Study coordinator: David Meyer, MD, MS, FACS
  • Email: David.E.Meyer@uth.tmc.edu
  • Phone: (713) 500-7244

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.